Agouni, AbdelaliTual-Chalot, SimonChalopin, MatthieuDuluc, LucieMody, NimeshMartinez, M. CarmenAndriantsitohaina, RamarosonDelibegovic, Mirela2014-12-042014-12-042014-12-15Agouni, A, Tual-Chalot, S, Chalopin, M, Duluc, L, Mody, N, Martinez, M C, Andriantsitohaina, R & Delibegovic, M 2014, 'Hepatic protein tyrosine phosphatase 1B (PTP1B) deficiency protects against obesity-induced endothelial dysfunction', Biochemical Pharmacology, vol. 92, no. 4, pp. 607-617. https://doi.org/10.1016/j.bcp.2014.10.0080006-2952ORCID: /0000-0002-2215-7952/work/147568295ORCID: /0000-0001-6193-3152/work/160847579http://hdl.handle.net/2164/4076Acknowledgments This work was supported by a Diabetes UK project grant to Dr M. Delibegović (BDARD08/0003597), Tenovus Scotland grant to Dr. M. Delibegovic and Dr. A. Agouni and travel grants from the Physiological Society and Company of Biologists to Dr. A. Agouni. Dr Delibegovic is also funded by an RCUK Fellowship, British Heart Foundation, EFSD/Lilly diabetes programme grant and the Royal Society. Dr Agouni is funded by the Royal Society and the Physiological Society. This work is supported by the INSERM and CHU of Angers. The authors are thankful to the functional imaging center of Angers (CIFAB) for the use of echocardiography.111190693engSDG 3 - Good Health and Well-beingPTP1Binsulin resistanceendothelial dysfunctiontyrosine phosphataseeNOSRM Therapeutics. PharmacologyRMJournal article10.1016/j.bcp.2014.10.008924